Germitec
PrivateLast Round
Series B
Feb 12, 2025
Total Funding Raised
$68.6M
Company Overview
Germitec is a medical devices company that provides UV-C technology for High-Level Disinfection (HLD) of ultrasound probes.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Germitec Comps
Public and private peers based on sector, stage, and business model.
Germitec Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 12, 2025 | ||||
| Debt | Nov 14, 2023 | ||||
| Series A | May 10, 2022 |
Key People
Founding team and executive leadership
Germitec Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Investment Bank Group | Debt |
| Aquiti Gestion | Series A |
| Galia Gestion | Series A |
| Eurazeo | Series B |
| Kurma Partners | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 4, 2025
Commercial launch of Chronos Max announced.
- Jun 3, 2025
Will attend the APIC 2025 Annual Conference.
Germitec Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Germitec's valuation, stock price, and market status.
